1. Home
  2. MUA vs YDES Comparison

MUA vs YDES Comparison

Compare MUA & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock MuniAssets Fund Inc

MUA

Blackrock MuniAssets Fund Inc

HOLD

Current Price

$9.70

Market Cap

666.0M

Sector

Finance

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$3.31

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUA
YDES
Founded
N/A
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
666.0M
543.0M
IPO Year
1994
2024

Fundamental Metrics

Financial Performance
Metric
MUA
YDES
Price
$9.70
$3.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
375.4K
409.2K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.62
$1.70
52 Week High
$11.48
$22.00

Technical Indicators

Market Signals
Indicator
MUA
YDES
Relative Strength Index (RSI) 33.59 45.26
Support Level N/A $2.99
Resistance Level $10.87 $5.15
Average True Range (ATR) 0.09 0.68
MACD 0.00 -0.12
Stochastic Oscillator 17.23 12.43

Price Performance

Historical Comparison
MUA
YDES

About MUA Blackrock MuniAssets Fund Inc

Blackrock Muniassets Fund Inc is a closed-end fund. Its objective is to provide high current income exempt from U.S. federal income taxes by investing in a portfolio of medium- to lower-grade or unrated municipal obligations. The Fund invests more of its total assets in municipal bonds.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: